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A B S T R A C T The raised transepithelial electric po-
tential difference (PD) across respiratory epithelia in
cystic fibrosis (CF) has suggested an abnormality in
ion permeation. We characterized this abnormality
further by measuring in the nasal epithelia of CF and
normal subjects the concentration-PD relationship for
amiloride, an inhibitor of cell Na' permeability, and
PD responses to superfusion with solutions of different
composition. Amiloride was more efficacious in the CF
subjects but the ED50 was not different from that of
normals (-2 X 10-6 M). Na' replacement by choline
induced effects similar to those of amiloride, i.e. a
greater depolarization in CF subjects. A 10-fold in-
crease in the K+ concentration of the perfusate induced
a small (<10 mV) depolarization in both subject pop-
ulations. When Cl- in the perfusate was replaced by
gluconate or SO2- the nasal PD of normal subjects hy-
perpolarized (lumen became more negative) by -35
mV. A significantly smaller response (<17 mV) was
induced in CF homozygotes but not in heterozygotes
(38 mV). The smaller response of CF subjects appears
to reflect an absolute decrease in luminal surface Cl-
permeability because pretreatment with amiloride did
not increase the response to Cl- free solution (7 mV).
Accordingly, three abnormalities (decreased Cl- per-
meability, raised PD, greater amiloride efficacy) have
been identified in CF respiratory epithelia. Whereas
"excessive" active Na+ transport can account for these
abnormalities and the dessication of airway surface
liquid, it is possible that a lower lumenal cell mem-
brane Cl- permeability and inhibition of a potential
path of Cl- secretion can also explain the observations.
INTRODUCTION
Cystic fibrosis (CF)' is characterized by abnormal fluid
and solute balance across the epithelia of several organs
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(1, 2). The lung is usually the critical organ because
thickened airway liquid appears to contribute to re-
current infection with progressive loss of ventilatory
function (3). We established that transepithelial elec-
tric potential differences (PD) across the nasal mucosa
and bronchi of patients with cystic fibrosis were at
least twice voltages from the same regions of normal
subjects, heterozygote subjects, or patients with dis-
eases that share some of the sequellae of cystic fibrosis
(4). The PD of both normal and CF subjects were in-
hibited by superfusion of amiloride onto the luminal
surface but the drug induced a greater change in CF
patients. The specificity of amiloride's action on other
epithelia suggested that the PD across upper airway
epithelia of normal and CF subjects was linked to the
translocation of Na+.
In this paper we attempt to more completely char-
acterize the paths of ion permeation across the nasal
epithelium of CF and normal subjects from measure-
ments of (a) the concentration-voltage relationship for
amiloride perfusion onto the nasal mucosa and (b)
biionic and dilution PDs generated by superfusion of
the luminal surface of the nasal mucosa with solutions
of different ionic composition.
METHODS
Subjects. (a) CF patients. The diagnosis of CF was es-
tablished by both clinical criteria and raised sweat electro-
lytes in 8 males and 12 females (mean age = 22.0 [±1.1] yr).
Because of the long duration of superfusion with solutions
of different ion composition (see below), the 14 subjects who
participated in these studies were at least 16 yr old. (b) Nor-
mal. Age and sex matched subjects (20 males, 23 females,
mean age = 21.1 [±1.2] yr) without history of respiratory or
other disease, medication use, or cigarette smoking, served
as controls. (c) Heterozygotes. Four CF mothers, mean age
29 (±4) yr, were studied.
Drugs and solutions. Mammalian Krebs bicarbonate
Ringer's solution (KBR) was the standard superfusion (5).
The Na+ concentration of the solution was reduced by re-
placing NaCl with choline Cl and choline bicarbonate (Sigma
Chemical Co., St. Louis, MO). The K+ concentration was
raised by replacing NaCl with KCl. The Cl- concentration
was reduced by replacing NaCl with Na gluconate (Sigma
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Chemical Co.), or in a few experiments, Na2SO4 that was
made isosmotic with mannitol. The NaCl of solutions that
were nominally free of both ions was replaced by choline
gluconate, which was prepared by titration of gluconic acid
with choline bicarbonate. Osmolality and the Na', K+, and
Cl- concentrations were within 7% of expected values. All
solutions were gassed with 95% 02-5% CO2 and had pH of
7.3-7.4. Amiloride HCI, a gift of Merck Sharp and Dohme,
Div. Merck, Inc., Rahway, NJ, was dissolved in the appro-
priate Ringer's solution.
Superfusion of the nasal surface. Responses of the nasal
transepithelial PD to superfusion with different solutions
were measured by a technique adapted from previous studies
(6). Briefly, a Ringer-agar reference bridge connected to a
calomel electrode was inserted subcutaneously. A double-lu-
men catheter was positioned at a site under the inferior tur-
binate, 1-3 cm from the anterior tip. Sites were chosen such
that slight movement did not change the PD. In general, the
PDs were typical of those reported for the inferior surface
(6). Ringer's solution that was connected by a Ringer-agar
bridge to a calomel electrode, was perfused slowly (0.2 ml/
min) through one lumen. The second tube was attached to
a glass coil in a 370C water-bath that was connected to a
separate perfusion pump. After the base-line measurement
(PD did not change by >6% during 1 min), perfusion through
the first pump was stopped and solution flow through the
second catheter was begun. For amiloride dose-effect studies,
the second perfusion rate was 0.4 ml/min for 3 min. Solutions
of different composition were superfused for 5 min at 4 ml/
min and then for 30 s at 15 ml/min. At the end of each
superfusion sequence, the nasal surface was superfused again
with Ringer's solution for 3 min. Subjects were exposed to
a superfusion sequence (usually one or two modified solu-
tions, see Tables I and II) no more frequently than once a
week. PDs between the exploring and subcutaneous bridges
were measured with a high impedence voltmeter and were
corrected for the appropriate liquid junction potential by
the method described previously (7).
Statistics. Mean changes in nasal voltage induced by
amiloride or by modification of superfusion solution com-
position in a group of subjects were evaluated by paired t
test. Differences between subject groups in base-line PD or
the magnitude of response to a maneuver were assessed by
the t test for independent means. P < 0.05 was considered
to be significant. Means (±SE) are reported.
RESULTS
The dose-effect relationship for nasal mucosa super-
fused with Ringer's solution in vivo with amiloride is
shown in Fig. 1. The average PD across the untreated
epithelium of 34 normal subjects was 29.1 (±1.6) mV
(lumen negative) whereas the corresponding voltage
in 18 CF subjects was 67.7 (±1.8) mV (lumen nega-
tive). Superfusion with amiloride induced a dose-de-
pendent inhibition of the voltage. Comparable con-
centrations of amiloride always induced a greater ab-
solute change in the PD of CF subjects. However, when
the change in voltage was normalized for the magni-
tude of the resting PD in each subject, only the max-
imal effect induced by concentrations of amiloride that
exceeded 10- M was significantly higher in CF sub-
jects. The doses required to reduce the PD of normal
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FIGURE 1 Dose-effect relationship for inhibition of nasal PD
by amiloride (moles per liter). The change in PD induced
by each concentration of amiloride was divided by the PD
recorded in each subject during superfusion with drug-free
Ringer's solution and the quotient was multiplied by 100.
Open circles and the dashed line represent results from nor-
mal subjects; filled circles and the solid line denote data from
subjects with cystic fibrosis. Each point is the mean of ob-
servations on the number (n) of subjects noted in parentheses.
Vertical bars denote SE.
x 10-6 M, respectively. Slightly greater inhibition
(<10%) could be induced by greater infusion rates (4
ml/min) but the drug always induced, at comparable
infusion rates, a greater maximal effect in CF than in
normal subjects.
Because the specificity of amiloride's inhibition of
Na' entry across the luminal border of epithelial cells
implied a contribution of Na' translocation to the PD
in nasal epithelia, we also assessed the voltage response
to superfusion with Na'-free solutions. Exposure to
Na' replete Ringer solution from the second pump did
not change PD (Table I). Like exposure to amiloride,
Na'-free solution induced large reductions in PD in
both groups and the response in CF subjects was both
absolutely and proportionately greater.
The PD change induced by this or any other mod-
ification of the superfusion solution was not signifi-
cantly different at the higher flow rate. This finding
indicates that the lower flow resulted in the maximal




Changes in the Bioelectric PD of the Nasal Mucosa of Normal and CF Subjects Induced
by Replacement of Cation in the Perfusion Solution
Subjects
Normal Cystic fibrosis
Base line Modified PD Base line Modified PD
(KBR) perfusate change' (KBR) persuate change'
PD(mV) PD(mV)
Composition and sequence of
superfusion of modified Mean Mean
solution t N (SEM) N (SEM)
KBR to KBR 7 -27.9 -29.4 -1.5 7 -70.8 -73.8 -3.0
(1.3) (1.9) (0.7) (4.7) (4.5) (1.3)
KBR to choline Cl- 7 -30.5 -7.9 +22.6§ 8 -70.5 -13.5 +57.0§1
(4.2) (2.1) (2.5) (5.4) (3.0) (3.5)
KBR to amiloride (10- M) 5 -30.8 -8.0 +22.8§ 5 -59.2 -11.2 +48.0§
in KBR (2.9) (0.4) (2.5) (3.2) (2.0) (1.9)
to amiloride (10-i M) -1.0 +7.0T -1.3 +9.91
in choline Cl- (1.7) (1.9) (3.0) (1.4)
KBR to 50 meq K+, 90 meq 6 -29.8 -21.6 +8.2§ 6 -65.8 -57.9 +7.9
Na+ (4.6) (5.2) (2.6) (4.7) (8.4) (3.7)
KBR to 50 meq choline, 90 5 -33.4 -29.3 +4.1 5 -71.6 -68.3 +3.3
meq Na+ (4.7) (5.1) (1.9) (8.4) (8.1) (4.1)
o A negative (-) change represents hyperpolarization, i.e., the lumen became more negative; a positive (+) change denotes depolarization.
t Drug and major solute composition, e.g., amiloride (10-3 M) in KBR to amiloride in choline Cl- = superfusion with amiloride (10-s
M) containing solution followed by superfusion with an amiloride containing solution with all Na+ replaced by choline.
§ Change from baseline (P < 0.05).
Different from change induced in normals (P < 0.05).
¶ Change induced from the steady state established by superfusion with the first modified solution (P < 0.05).
change in composition in the vicinity of the exploring
bridge. In addition, reexposure of the nasal epithelium,
after each sequence of ion replacement (without
amiloride), to conventional Ringer solution established
a steady-state PD that was not significantly different
from the initial base line (data not shown).
Since superfusion with Na'-free solution with ami-
loride after amiloride pretreatment resulted in a <10
mV further decrease in the PD of the nasal epithelia
of both groups (Table I), we reasoned that most of the
PD change induced by Na'-free Ringer was amiloride
sensitive. The amiloride insensitive responses of the
two subject populations were not different.
The exaggerated response of CF airways to amilor-
ide or Na' replacement suggested that the path of Na+
permeation played a disproportionately greater role
in the determination of PD in CF epithelium. How-
ever, this pattern of response would also be expected
if Na' permeation was "normal" and permeability of
the barrier to other ions was abnormally low. We eval-
uated this alternative by assessing the transepithelial
voltage response to changes in the concentration of
other major ions in the solution that was superfused
onto the surface of the nasal mucosa.
When the K+ concentration was raised 10-fold to 50
meq/liter, PD across the nasal mucosa of both groups
of subjects fell by -8 mV. The change in CF subjects
was not significant. Replacement of an equivalent con-
centration of Na' in the bathing solution by choline
did not change the PD in both groups of subjects sig-
nificantly. Although the response to K+ replacement
tended to be slightly greater than that to choline, the
differences were not significant.
In contrast, replacement of Cl- by gluconate or sul-
fate resulted in a rise in the PD of normal subjects that
was more than twice that of CF subjects (Fig. 2 and
Table II). Further, the voltage change induced by su-
perfusion with Cl--free media did not require Na' in
the solution (NaCl replaced by choline gluconate). A
PD change of 38 (±4) mV was induced in four het-




FIGURE 2 Typical time course of nasal PD of a normal sub-
ject (panel A) and a subject with cystic fibrosis (panel B).
Arrows on the left denote switch from superfusion (0.2 ml/
min) with conventional Ringer's solution to a solution in
which all Cl- was replaced by gluconate (4 ml/min). Arrows
on the right indicate an increase in the rate of superfusion
with Cl- free solution to 15 ml/min. PD during superfusion
with Cl- free solution is not corrected for the tip potential
of the bridge on the nasal surface and is underestimated by
9 mV.
erozygotes by superfusion with Cl--free solution. This
response was not different from that of normal sub-
jects.
The relative permeabilities of Na' and Cl- across
nasal epithelium can also be assessed from the PD
change induced by isosmotic dilution of NaCl with a
nonelectrolyte (sucrose). First, we measured the effect
of the change in Na' concentration alone (replacement
with choline) and then superfused with diluted Ringer's
solution. Small but significant reductions in the PD of
both groups accompanied exposure to 60 meq/liter
Na'. The response of CF subjects was greater. Sub-
sequent ion dilution and choline removal resulted in
a substantial increase in the PD of normals and an
insignificant change in CF subjects.
The blunted response of CF nasal epithelia to C1--
free solution could reflect lower relative or absolute
Cl- permeability. We tried to distinguish between
these alternatives by inhibiting Na' permeability with
amiloride and then measuring the response to a C1--
free solution with amiloride. Pretreatment with ami-
loride induced the characteristic fall in PD. Subse-
quent perfusion with amiloride in Cl--free solution
induced an increase in PD of normal subjects that was
similar to voltage change induced by Cl--free solution
without drug. The voltage response in CF subjects was
again smaller than that of normals. Compared with
CF subjects that were not pretreated with amiloride,
the response of CF subjects to Cl--free solution with
amiloride was smaller.
DISCUSSION
Transepithelial electric PDs under the inferior turbi-
nate were twofold greater in CF than in normal sub-
jects (Tables I and II). These results are comparable
to our earlier measurements of a larger CF popula-
tion (4).
The dose-effect study with amiloride (Fig. 1) dem-
onstrated that the drug induced a greater ceiling effect
on the nasal PD of CF subjects. Both absolute voltage
changes and the changes normalized for base-line PD
that were induced by maximal concentrations of
amiloride were always greater in CF than in normal
subjects (Fig. 1 and Table I). However, ED50 of normal
subjects and subjects with cystic fibrosis were similar
(2 or 3 X 106 M). These values fall into the range
reported for respiratory epithelia excised from adult
human subjects (8) and for the other Na+ absorbing
epithelia (9). In addition, similar dose-effect relation-
ships for PD or short circuit current have been ob-
tained in vitro from nasal and bronchial epithelia ex-
cised from CF and normal subjects.2
Amiloride's primary action on CF and normal nasal
mucosa is probably restricted to cellular paths of Na'
translocation. An in vitro study of nasal epithelia ex-
cised from a limited number of normal and CF subjects
demonstrated that Na' absorption was the only mea-
surable active ion transport across these tissues under
resting conditions.2 Moreover, basal Na+ transport
equalled the short circuit current and was blocked by
amiloride. It is more difficult to test amiloride speci-
ficity in vivo. The similarity between PD changes in-
duced by amiloride and by Na'-free solution could
result from a common mechanism. However, drug-in-
duced and Na+-free voltage responses of the nasal
mucosa would not be expected to be identical. For
example, whereas both maneuvers limit the access of
Na+ to the transport system, only replacement of Na+
in the superfusion is likely to reverse the Na+ gradient
across the luminal (apical) membranes of the epithelial
cells and should not affect Na+ permeability. In spite
of these differences, replacement of Na+, like exposure
to amiloride, induced a greater change in PD in CF
than in normal subjects. Because replacement of Na+
in a Ringer solution that contained a maximal concen-
2 Knowles, M. R., M. J. Stutts, A. Spock, N. Fischer, J. T.
Gatzy, and R. C. Boucher. Abnormal ion permeation through
cystic fibrosis respiratory epithelium. Science (Wash. DC).
In press.
Knowles, M. R., A. Spock, J. T. Gatzy, and R. C. Boucher.
1982. Amiloride sensitivity and ion permeabilities of CF and
normal human bronchi. Clin. Res. 30: 861a. (Abstr.)
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TABLE II
Changes in the Bioelectric PD of the Nasal Mucosa of Normal and CF Subjects Induced by Replacement of Anion,
Cation and Anion, and by Ion Dilution of the Perfusion Solution
Subjects
Normal Cystic fibrosis
Base line Modified PD Base line Modified PD
(KBR) perfusate change' (KBR) perfusate change'
PD(mV) PD(mV)
Composition and sequence of
superfusion of modified Mean Mean
solutiont N (SEM) N (SEM)
KBR to Na+ gluconate 16 -29.0 -63.4 -34.4§ 14 -59.3 -75.6 -16.3§
(2.7) (3.2) (2.4) (3.6) (4.8) (2.6)
KBR to Na+ sulfate 4 -31.6 -68.2 -36.6§ 3 -66.3 -74.6 -8.3"1
(6.2) (5.5) (2.3) (4.7) (1.9) (3.2)
KBR to choline Cl- 3 -32.3 -10.9 +21.4§ 3 -67.0 -25.2 +41.8§
(5.8) (3.4) (4.8) (10.7) (5.0) (8.0)
to choline gluconate -37.1 -26.2¶ -22.0 +3.2"1
(2.1) (3.4) (3.4) (6.1)
KBR to 60 meq Na+, 80 meq 5 -27.8 -21.1 +6.7§ 4 -70.5 -59.6 +10.95
choline, 120 meq Cl- (2.6) (3.0) (0.9) (7.8) (6.8) (1.1)
to 60 meq Na+, 40 meq -43.8 -22.7¶ -65.9 -6.3"1
Cl-, 160 mM sucrose (5.9) (3.2) (5.1) (3.9)
KBR to amiloride (10-4 M) in 11 -30.2 -9.2 +21.0§ 10 -67.0 -14.6 +52.41
KBR (2.6) (1.5) (2.1) (4.9) (2.7) (5.1)
to amiloride (10-4 M) in -38.1 -28.9¶ -21.5 -6.9"1
Na+ gluconate (2.5) (2.4) (2.8) (1.3)
e A negative (-) change represents hyperpolarization, i.e., the lumen became more negative; a positive (+) change denotes depolarization.
t Drug and major solute composition, e.g., choline Cl- to choline gluconate = superfusion with a solution with all Na+ replaced by
choline followed by superfusion with solution with all NaCl replaced by choline gluconate.
§ Change from base line (P < 0.05).
Different from change induced in normals (P < 0.05).
¶ Change induced from the steady-state established by superfusion with the first modified solution (P < 0.05).
tration of amiloride induced an additional depolariza-
tion that was similar in CF and normal subjects, we
conclude that most of the voltage response to Na'-free
solution alone was the consequence of Na' permeation
through amiloride-sensitive paths and that amiloride-
insensitive Na' paths make a similar contribution to
the responses of both populations of subjects. In ad-
dition, preliminary data suggest that the small (<20%
or 1 ms/cm2) reduction in conductance of excised air-
way epithelia (nasal turbinate and polyp, bronchi) in-
duced by amiloride is not greater in tissue from CF
subjects.2 These results imply that amiloride-sensitive
ion fluxes across CF airway epithelia do not, compared
to paths across normal tissue, contribute dispropor-
tionately to conductance.
subjects. A 10-fold increase in the K+ concentration
of the superfusion solution resulted in a small depo-
larization that was not significantly different in either
population from the response induced by replacement
of an equivalent amount of solution Na+ by choline.
These results suggest that the epithelial surface is not
K+ permselective. Our experience with other airway
epithelia has shown that equivalent radii of paths
around the surface cells are large (>4 nm) and would
not be expected to restrict small ion movement (10,
11). The similar voltage responses of CF and normal
subjects to the high K+ solution imply that the K+ per-
meabilities of the luminal cell membrane and the para-
cellular path are comparable in both populations of sub-
jects.
The voltage change induced by one other modifi- In contrast, replacement of Cl- in the superfusion
cation of Ringer's solution was not "abnormal" in CF solution with or without Na' induced a greater hy-
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perpolarization of the nasal PD of normal than CF
subjects. If Cl- and gluconate diffusion in the para-
cellular shunt follow the expectations for diffusion in
free solution, this path can contribute no more than
9 mV to the hyperpolarization (i.e., equal and opposite
to the liquid junction PD at the bridge). Consequently,
the response in normal subjects probably reflects C1-
permselectivity of the apical surface. This conclusion
is supported by the hyperpolarization induced by di-
lution of the NaCl in the superfusion solution with
isosmotic sucrose (Table II). It is likely that the C1-
permeability of the luminal surface of the epithelium
of CF subjects is substantially smaller. Not only was
the PD response to Cl- replacement smaller than the
response of normals, but Cl- replacement coupled with
a maximal concentration of amiloride, a maneuver that
would be expected to minimize the contribution of
Na' diffusion to the PD, decreased rather than in-
creased the hyperpolarization. Accordingly, both the
relative and absolute Cl- permeability of the apical
surface of CF epithelium appear to be smaller than
those of normal subjects. These differences probably
cannot be accounted for by differences between the
ion composition of normal and CF epithelium because
the change in PD across the barrier should be inde-
pendent of cell and interstitial ion concentrations so
long as these concentrations do not change during the
period of measurement (12).
Our studies of bioelectric properties and ion flow
across airway epithelia have revealed three major dif-
ferences between normal and CF tissue. CF epithelia
are characterized by (a) a greater transepithelial PD,
(b) a greater maximal response to amiloride, and (c)
a smaller Cl- permselectivity of the luminal surface.
Several defects or a single defect could account for
these observations. We originally proposed on the basis
of increased amiloride efficacy that the raised PD or
airway epithelia was the consequence of an "excessive
Na' absorption" (4). This hypothesis is neither sup-
ported nor discounted by the present study or by our
limited observations from airway epithelia excised
from normal and CF subjects.2 We considered earlier
the possibility that a defect in the Na+ transport could
result from a change in paracellular Na+ conductance,
Na+ entry into or active Na+ extrusion from the epi-
thelial cells (4). Measurements that are likely to be
related to the passive Na+ permeability of paths
through (amiloride-sensitive conductance2 and ami-
loride affinity for tissue receptors [Fig. 1]) and/or
around epithelial cells (amiloride-insensitive Na+ per-
meability [Table I]) appear to be similar in both subject
populations. These findings indicate that any "exces-
sive" Na+ absorption across CF tissue is probably not
a consequence of an increased density of Na+ entry
sites. Hence, an increased rate of active Na+ transport
would require in CF a greater driving force(s) for en-
try, specifically, decreased cell Na+ concentration
and/or increased intracellular negativity.
A raised PD associated with increased active Na+
transport in CF airway epithelia could also cause a
decrease in apical Cl- permeability. Voltage depen-
dent Cl- permeability of electrically excitable mem-
branes is well documented (13). Certain methods of
depolarization of excised airway epithelia, e.g., raised
submucosal K+ concentration, increase transepithelial
Cl- permeability (14). However, effects of hyperpo-
larization on Cl- permeability have not been reported.
Alternatively, the small Cl- permeability of the lu-
minal border of the CF nasal epithelium raises the
possibility that this defect alone could explain the ab-
normalities we observed. For example, we have noted
a pattern of amiloride action on airway epithelia (15-
17). Despite the fact that Na+ absorption accounted
for >75% of the basal short circuit current, the drug
inhibited short circuit current or PD -50%. This dis-
crepancy does not reflect an amiloride-insensitive Na+
absorptive flow (because Na+ absorption was abol-
ished), but rather, the induction of Cl- secretion. A
similar pattern of ion flow was induced by exposure
to the luminal surface to Na+-free solution (16, 17).
The proposed mechanism for this Cl- secretion is re-
lated to an increase in the electrical force that drives Cl-
passively across the luminal membrane and has been de-
scribed elsewhere (16, 18). If Cl- permeability of the
apical surface is lower in CF airway epithelia, then C1-
secretion cannot be induced by amiloride and the PD
(or short circuit current) in the presence or absence of
drug would be related only to the rate of Na+ absorption.
The expected result is greater amiloride efficacy in CF
tissue.
It is more difficult to explain the raised PD of CF
airway epithelia with this model. On the assumption
that Cl- permeation is the major determinant of apical
(luminal) membrane PD of normal airway epithelia,
a lower apical Cl- permeability in CF would shift
determination of the PD to the ion species with the
largest product of permeability and average trans-
membrane concentration. If this ion is Na+, then the
lumen should become more negative. This hypothesis
is supported by the inverse relationship between rest-
ing PD and transepithelial Cl- permeability of rabbit
trachea (19) and canine bronchi (18). However, there
are few, if any, maneuvers that unequivocally test this
hypothesis. Removal of Cl- from the luminal solution
induced the expected hyperpolarization of nasal (Ta-
ble II) and other airway epithelia (16, 18) but Cl-
permeability was probably not affected, so that Cl-
gradients could still contribute to the PD. Indometh-
acin has been touted as an agent that selectively in-
hibits the Cl- permeability of apical membranes of the
surface epithelium of excised canine trachea (20).
Even though the canine trachea secretes Cl- by a
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mechanism that appears to be similar to that of fourth
to sixth generation bronchi (18), indomethacin depo-
larizes the trachea (21) and hyperpolarizes large bron-
chi only slightly (unpublished).
Any explanation of an epithelial defect(s) in CF
should be compatible with the composition of the liq-
uid that fills or lines the epithelial lumen. Although
evaluation of airway surface liquid composition may
be complicated by chronic airway infection (3), the
liquid in the lumens of airways (22, 23) and of other
uninfected epithelial structures appears to be dehy-
drated (1). It is obvious that raised or "excessive" ac-
tive Na+ transport across the superficial epithelium
that drives Cl- and water from the luminal surface of
airways could result in dessication of the macromol-
ecules left behind. Since the permeability of the cel-
lular path to Cl- in CF is small, the transport force
would have to be great enough to drive most of the
counterion flow through the large paracellular paths.
In contrast, if the abnormality in respiratory epithelia
is reflected in a smaller Cl- permeability and the active
Na+ transport path is normal, then the control of air-
way surface liquid composition and volume is more
complex. For example, Schulz (24) and Quinton (25)
have suggested that an increased resistance to coun-
terion movement (decreased Cl- permeability) retards
hyperosmotic Na+ absorption by the CF sweat duct
epithelium, thereby increasing the NaCi in and os-
molality of sweat. Consequently, sweat duct and air-
way epithelium may share a common defect in ion
permeability. However, liquid on the bronchial sur-
face is probably isosmotic (26), so that inhibition of
NaCl absorption would be expected to retain volume
on airway surfaces, a prediction that is not consistent
with measurements of thicker, "dessicated" surface
liquid in CF airways. On the other hand, reduced Cl-
permeability that results in decreased Cl- secretion in
CF would remove a driving force that tends to add
salt and water to the airway surface. Normal Na+
transport would continue to drive volume away from
the surface. The result is raised net salt and water
absorption by CF airways.
We have no evidence that the missing path of Cl-
permeation in CF contributes to dehydration of airway
surface liquid, and the evidence that Cl- secretion by
the superficial epithelium may play a role in the reg-
ulation of surface liquid of normal airways in vivo is
limited. We "artifically" induced Cl- secretion in
bronchi by treatment of the luminal surface with
amiloride or by replacement of Na+ in the luminal
bathing solution. Indole compounds, such as serotonin,
have been shown to exert an amiloride-like action on
excised primate bronchi (27). Histochemical data sug-
gest that similar compounds are contained in neu-
roendocrine cells that lie beneath the airway epithe-
lium. We do not know that these substances are re-
leased from the cells of storage nor can we predict that
an effective concentration would accumulate near the
site of action. Consequently, it is difficult to know
whether these or other compounds affect Na+ per-
meability in vivo by an amiloride-like mechanism that
may also induce Cl- secretion.
Other endogenous substances affect Cl- secretion by
airways more directly. fl-adrenergic agents induce
changes in bioelectric properties of surface cells (21),
and induce Cl- secretion in canine trachea (28). fl-
adrenergic agonists also tend to induce the secretion
of Cl- by canine (29) and human bronchi (15) but the
magnitude of the response is relatively small (10% in-
crease). Accordingly, there is evidence that neuro-
transmitters, neurohumors, and autocoids can modu-
late Cl- secretion by airway surface epithelia but there
are no direct studies that measure the magnitude of
this modulation.
It is also possible that defects in the function of air-
way surface epithelial cells play a minor role in liquid
balance and that dysfunction of glandular secretion
in all regions and/or of the surface epithelia of small
airways are responsible for the major derangement of
airways surface liquid in CF. Cells in the latter region
are thought to secrete liquid (30). This secretion may
be a vestige of volume flow that is driven by Cl- trans-
port across the pulmonary epithelium of the fetus. But,
there is no direct evidence for the production of sur-
face liquid by distal airways or its control. In contrast,
the salt and water output of glands in large airways
is modulated by cholinergic and, in some species, ad-
renergic neurotransmitters (31). Whereas the output
of mucous glycoprotein onto airway surfaces appears
to be normal in CF (32), secretion of NaCl and water
by glands has not been examined. Secretion of liquid
by the acinus of sweat glands, however, has been stud-
ied and is normal (24).
Finally, our finding of decreased airway Cl- per-
meability in CF does not affect the rationale for con-
sideration of agents such as amiloride for treatment
of the disease. Inhibition of Na+ (and, presumably, C1-
and water) absorption remains a possible therapeutic
objective, even though the diseased epithelium may
lack a potential compensatory process (Cl- secretion).
Consequently, optimal surface liquid volume and com-
position may be even more difficult to achieve than
we had originally supposed.
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